Toxoplasma gondii Antibody, IgG and IgM
Nervous System/Brain Cancer Panel, NGS
Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Confirmation
Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
CHEK2 Gene Mutation Analysis
Ribonucleoprotein P (U1RNP) Antibody (ENA)
IgG Index, CSF
Coagulation Factor VII Activity Assay, Plasma
Bacterial Culture, Upper Respiratory
2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
References
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...